Exelixis
EXEL
#2109
Rank
S$9.81 B
Marketcap
$34.41
Share price
-1.53%
Change (1 day)
16.82%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total assets

Total assets on the balance sheet as of June 2024 : S$3.61 B

According to Exelixis's latest financial reports the company's total assets are S$3.61 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exelixis - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31S$3.88 B-5.63%
2022-12-31S$4.11 B16.7%
2021-12-31S$3.52 B24.87%
2020-12-31S$2.82 B11.44%
2019-12-31S$2.53 B30.87%
2018-12-31S$1.93 B121.06%
2017-12-31S$0.87 B1.65%
2016-12-31S$0.86 B83.24%
2015-12-31S$0.47 B10.16%
2014-12-31S$0.42 B-33.03%
2013-12-31S$0.63 B-27.73%
2012-12-31S$0.88 B73.26%
2011-12-31S$0.50 B9.54%
2010-12-31S$0.46 B-3.66%
2009-12-31S$0.48 B-16.44%
2008-12-31S$0.57 B-3.08%
2007-12-31S$0.59 B-1.72%
2006-12-31S$0.60 B9.45%
2005-12-31S$0.55 B28.95%
2004-12-31S$0.42 B-29.45%
2003-12-31S$0.60 B3.49%
2002-12-31S$0.58 B-8.3%
2001-12-31S$0.64 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
S$95.69 B 2,549.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$181.17 B 4,915.83%๐Ÿ‡ซ๐Ÿ‡ท France
S$146.70 B 3,961.49%๐Ÿ‡บ๐Ÿ‡ธ USA
S$123.28 B 3,312.98%๐Ÿ‡บ๐Ÿ‡ธ USA
S$118.41 B 3,178.15%๐Ÿ‡บ๐Ÿ‡ธ USA
S$235.87 B 6,430.12%๐Ÿ‡บ๐Ÿ‡ธ USA
S$281.60 B 7,696.02%๐Ÿ‡บ๐Ÿ‡ธ USA
S$65.66 M-98.18%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.13 B-96.35%๐Ÿ‡บ๐Ÿ‡ธ USA